Advertisement
Screener

Allarity Therapeutics, Inc. (ALLR) Current Assets

2.8 / 5 stars · 68/120 Roast Me

Allarity Therapeutics, Inc. Current Assets

Allarity Therapeutics, Inc. (ALLR) had Current Assets of $31.73 million as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Balance Sheet › Assets › Assets, Current

us-gaap:AssetsCurrent · last filed 2026-08-14

  • 2026-06-30: Assets, Current $31.73M.
  • 2026-03-31: Assets, Current $34.50M.
  • 2025-12-31: Assets, Current $17.93M.
  • 2025-09-30: Assets, Current $20.47M.
Period endAssets, CurrentAssets, Current as first filed
2026-06-30$31.73M
10-Q · filed 2026-08-14
2026-03-31$34.50M
10-Q · filed 2026-05-15
2025-12-31$17.93M
10-Q · filed 2026-08-14
2025-09-30$20.47M
10-Q · filed 2025-11-14
2025-06-30$20.88M
10-Q · filed 2025-08-15
2025-03-31$29.42M
10-Q · filed 2025-05-09
2024-12-31$22.34M
10-K · filed 2026-03-30
2024-09-30$20.37M
10-Q · filed 2024-11-14
2024-06-30$21.31M
10-Q · filed 2024-08-05
2024-03-31$2.29M
10-Q · filed 2024-05-14
2023-12-31$1.97M
10-K · filed 2025-03-31
2023-09-30$4.39M
10-Q · filed 2023-11-14
2023-06-30$3.69M
10-Q · filed 2023-08-14
2023-03-31$2.97M
10-Q · filed 2023-05-11
2022-12-31$4.97M
10-K · filed 2024-03-08
2022-09-30$6.06M
10-Q · filed 2022-11-14
2022-06-30$10.12M
10-Q · filed 2022-10-07
2022-03-31$17.21M
10-Q · filed 2022-05-27
2021-12-31$21.40M
10-K · filed 2023-03-13
$21.05M
10-K · filed 2022-05-17
2021-09-30$7.63M
10-Q/A · filed 2022-05-17
2020-12-31$1.72M
10-Q/A · filed 2022-05-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Lipocine Inc. (LPCN)United States$0.017B-1.79
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B